KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Asset Writedowns and Impairment: 2011-2025

Historic Asset Writedowns and Impairment for National Health Investors (NHI) over the last 5 years, with Jun 2025 value amounting to -$1.4 million.

  • National Health Investors' Asset Writedowns and Impairment fell 225.95% to -$1.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.8 million, marking a year-over-year increase of 1.76%. This contributed to the annual value of $5.3 million for FY2024, which is 284.81% up from last year.
  • National Health Investors' Asset Writedowns and Impairment amounted to -$1.4 million in Q2 2025, which was down 9,850.00% from -$14,000 recorded in Q1 2025.
  • In the past 5 years, National Health Investors' Asset Writedowns and Impairment registered a high of $29.2 million during Q4 2021, and its lowest value of -$1.4 million during Q2 2025.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $98,000 (2023), whereas its average is $526,400.
  • As far as peak fluctuations go, National Health Investors' Asset Writedowns and Impairment skyrocketed by 265,281.82% in 2021, and later plummeted by 240.00% in 2025.
  • National Health Investors' Asset Writedowns and Impairment (Quarterly) stood at $29.2 million in 2021, then declined by 24.72% to $22.0 million in 2022, then crashed by 101.60% to -$351,000 in 2023, then surged by 312.25% to $745,000 in 2024, then tumbled by 225.95% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q2 2025, -$14,000 for Q1 2025, and $745,000 during Q4 2024.